A detailed history of Bay Bridge Capital Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bay Bridge Capital Group, LLC holds 682 shares of LLY stock, worth $523,612. This represents 0.44% of its overall portfolio holdings.

Number of Shares
682
Previous 722 5.54%
Holding current value
$523,612
Previous $653 Million 7.52%
% of portfolio
0.44%
Previous 0.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $30,885 - $38,400
-40 Reduced 5.54%
682 $604 Million
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $13,772 - $17,271
19 Added 2.7%
722 $653 Million
Q1 2024

Apr 26, 2024

SELL
$592.2 - $792.28 $48,560 - $64,966
-82 Reduced 10.45%
703 $514 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $412,274 - $486,017
785 New
785 $504 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bay Bridge Capital Group, LLC Portfolio

Follow Bay Bridge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Bridge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Bridge Capital Group, LLC with notifications on news.